Hawaii 2023 Regular Session

Hawaii Senate Bill SB615

Introduced
1/20/23  

Caption

Relating To Education.

Impact

The introduction of this bill signifies a proactive approach to managing severe allergic reactions within school environments, particularly for students who may be at risk of anaphylaxis. By ensuring that schools are prepared to respond to such emergencies, this legislation is anticipated to improve the overall safety and health management practices across educational facilities. The requirement for clear signage regarding anaphylaxis symptoms and administration methods is also a critical component, which serves to educate both staff and students about potential health risks.

Summary

SB615 is a legislative bill in Hawaii aimed at enhancing public school safety by requiring that each public and public charter school has trained personnel available to administer epinephrine. The bill mandates that these staff members must be authorized to administer the medication and sets a ratio for staffing based on student population or school building floors. Specifically, it requires at least one trained staff member for every one hundred students or one per each floor of the school building, whichever is greater.

Contention

Discussions surrounding SB615 may raise points of contention related to the implementation of the bill, including the financial aspects of training staff and the allocation of resources necessary for compliance. Furthermore, debates may focus on the adequacy of training provided, the balance of responsibility placed on school staff, and whether such mandates could lead to increased liability for schools. Moreover, considerations on whether to exempt certain schools based on size or resources could also emerge as a topic of discussion as the bill progresses through the legislative process.

Companion Bills

No companion bills found.

Similar Bills

NH HB63

Relative to the use of nasal spray to treat anaphylaxis.

TX SB1619

Relating to the use of an epinephrine delivery system by certain entities.

TX HB2283

Relating to the use of an epinephrine delivery device by certain entities.

NH HB677

Relative to the possession and use of epinephrine at recreation camps, schools, and institutions of higher education.

NJ A181

Expands epinephrine administration mechanisms permitted in schools.

NJ S3869

Broadens epinephrine administration mechanisms permitted in schools, institutions of higher education, and youth camps.

NJ A4656

Broadens epinephrine administration mechanisms permitted in schools, institutions of higher education, and youth camps.

NJ S3624

Concerns food allergy safety, emergency preparedness, and anaphylaxis response in child care settings.